About
Clyde Biosciences is a Glasgow-based contract research organization specializing in in vitro cardiomyocyte assays using its CellOPTIQ® platform to provide functional cardiac safety and drug discovery data with human iPSC-derived cardiomyocytes aligned with regulatory CiPA guidance.
Explore Clyde Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.